Signal Transduction Pathways in Depth
- Compare G-protein-coupled receptors, receptor tyrosine kinases, and intracellular receptors by ligand type and mechanism
- Quantify signal amplification across a multi-step phosphorylation cascade and explain the role of second messengers
- Explain how pathways are terminated and how signaling triggers apoptosis
Three receptor classes — and why ligand chemistry decides which
A ligand’s chemistry dictates its receptor. Most signaling molecules are hydrophilic (water-soluble) — peptides, most neurotransmitters, epinephrine — so they cannot cross the hydrophobic core of the plasma membrane and must bind a surface receptor. Two families dominate the surface. A G-protein-coupled receptor (GPCR) activates a separate G protein by catalyzing a GDP → GTP swap; the activated G protein switches on a target enzyme (often adenylyl cyclase). A receptor tyrosine kinase (RTK) does something different: ligand binding drives two monomers to dimerize, and the paired receptors cross-phosphorylate each other’s tyrosines, creating multiple docking sites that can launch several pathways at once from a single ligand. The third class is for hydrophobic, lipid-soluble ligands — steroid hormones such as estrogen, testosterone, and cortisol — which diffuse straight through the membrane and bind an intracellular (often nuclear) receptor. That receptor-ligand complex acts as a transcription factor, binding DNA to switch genes on or off directly, with no membrane relay at all.
Transduction: cascades, second messengers, and quantified amplification
Once a surface receptor fires, the message travels inward as a phosphorylation cascade: an active kinase phosphorylates and activates the next kinase, which activates the next, and so on. Because each kinase is a catalyst, it activates many copies of its target before switching off — so the cascade is not just a relay but a multiplier. Second messengers carry the signal in parallel: cyclic AMP (cAMP), made from ATP by adenylyl cyclase, and Ca²⁺, released from stores into the cytosol. The quantitative payoff is enormous. If a cascade has three catalytic steps and each activated enzyme produces 100 active products, then a single activated receptor yields 100 × 100 × 100 = 10⁶ final molecules. Add a fourth step and you reach 10⁸ — one receptor, a hundred million products. This is why hormones circulate at nanomolar concentrations yet mobilize grams of stored fuel.
Response, termination, and apoptosis
The response is the endpoint — an enzyme activated, an ion channel opened, a gene transcribed. Just as important is termination: a signal that could not be shut off would lock the cell in one state. Cells switch pathways off at every level. A G protein is a built-in timer: it hydrolyzes its own GTP back to GDP, turning itself off seconds after activation. The enzyme phosphodiesterase degrades cAMP back to AMP, and protein phosphatases strip the activating phosphates off the cascade kinases. Because termination is constant, a sustained response requires continued ligand binding. One especially decisive response is apoptosis — programmed cell death. Unlike the messy rupture of necrosis, apoptosis is an orderly, tightly regulated self-destruction: signals activate caspases (protein-cleaving enzymes) that dismantle the cell into membrane-wrapped fragments, which neighbors clear without inflammation. Apoptosis sculpts developing tissues (fingers separate as webbing dies) and eliminates cells with irreparable DNA damage before they can become cancerous.
One epinephrine molecule binds a liver-cell GPCR. Its activated adenylyl cyclase makes 100 cAMP; the resulting active protein kinase A activates 100 phosphorylase kinase; each phosphorylase kinase activates 100 glycogen phosphorylase; each glycogen phosphorylase cleaves 100 glucose-1-phosphate from glycogen. How many glucose-1-phosphate molecules result from that one hormone, and what general principle does the number illustrate?
- 1.Count the catalytic (enzyme) steps that each multiply the signal ~100-fold: (1) adenylyl cyclase → cAMP, (2) protein kinase A → phosphorylase kinase, (3) phosphorylase kinase → glycogen phosphorylase, (4) glycogen phosphorylase → glucose-1-phosphate. That is 4 amplifying steps.
- 2.Amplification compounds multiplicatively, not additively: 100 × 100 × 100 × 100 = 100⁴.
- 3.Evaluate: 100⁴ = (10²)⁴ = 10⁸ = 100,000,000 glucose-1-phosphate molecules.
- 4.Interpret: one ligand → one hundred million products because every catalytic step multiplies the running total, so the amplification grows as a power of the number of steps.
Estrogen (a steroid) binds a receptor inside the cell, whereas epinephrine (an amine) binds a receptor on the cell surface. What property of the two ligands best explains this difference?
Amplification is multiplicative, not additive. Three catalytic steps of ×100 give 100³ = 10⁶, not 300. On the exam, multiply the per-step factors (or raise one factor to the power of the step count) — never add them.
A transduction pathway has three sequential enzymatic steps, and each activated enzyme activates about 1,000 molecules of the next component. Starting from a single activated receptor, roughly how many final product molecules are generated?
A drug blocks the ability of a G protein to hydrolyze its bound GTP to GDP. What is the most likely effect on signaling through that G protein’s pathway?
For AP free-response, treat termination as a required half of the answer: name a specific off-switch (G protein hydrolyzes GTP → GDP, phosphodiesterase degrades cAMP, phosphatases remove phosphates) and note that a sustained response needs continued ligand. Losing an off-switch causes constant, unregulated signaling — a common cancer mechanism.
Answer the 3 checkpoints as you read.
Sign in to save your progress